Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing
THE EFFECT OF WEB-BASED EDUCATION GIVEN TO WOMEN ON THEIR ATTITUDES AND BELIEFS ABOUT HPV TESTING
Cervical cancer is a highly preventable public health issue that significantly impacts women's quality of life. Although effective screening programs such as Human Papilloma Virus (HPV) testing and Pap-smears are widely available, women's participation in these early detection services often remains limited. The primary barriers to screening attendance include insufficient education, lack of information, negative beliefs, psychosocial or cultural factors, and misconceptions regarding gynecological examinations. To improve screening uptake, health interventions must focus not only on increasing knowledge but also on promoting correct beliefs and positive attitudes toward testing.
Web-based health education serves as an effective method to overcome barriers such as cost, transportation difficulties, and geographical limitations, allowing wider access to healthcare guidance. This study aims to evaluate the effects of a specialized web-based educational intervention on women's attitudes and beliefs regarding the HPV test. The research is designed as a randomized controlled trial with a pre-test and post-test design. Participants will be assigned to either an intervention group or a control group. The intervention group will receive structured health education through a dedicated web platform, while the control group will receive routine standard follow-up. Data will be gathered using a specific attitude and belief scale before and after the application to measure the intervention's impact.
調査の概要
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：MERVE İÇÖZ, Phd Student, Msc Midwife
- 電話番号：+905072094020
- メール：merve.icoz@ogr.sakarya.edu.tr
研究連絡先のバックアップ
- 名前：ZEKİYE TURAN, Phd, Associate Professor
- 電話番号：+905055376788
- メール：zekiyeturan@sakarya.edu.tr
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Having no prior clinical diagnosis of cervical cancer
- Being between 18 and 60 years of age
- Having active access to the internet
- Being literate at a level sufficient to read and understand the questionnaire forms
- Being capable of effectively navigating and using a web browser
- Being registered as a patient at Sakarya Akyazı No. 3 Family Health Center
- Volunteering to participate in the study and providing informed consent
Exclusion Criteria:
- Withdrawing from the study voluntarily at any stage
- Failing to watch the mandatory educational videos on the platform
- Submitting incomplete or incorrect responses to the data collection tools
- Lacking active internet access or proper web browser usage skills
Criteria for Study Discontinuation / Drop-out:
- Participant's request to withdraw from the study
- Failure to respond to or complete the data collection tools
- Not using or logging into the web application for more than 2 consecutive weeks during the study period
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：防止
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Intervention Group
Participants in this group will receive access to the web-based health education platform developed for the study.
|
Participants in the intervention group will receive health education through a specially designed web-based platform containing 11 presentations in total (8 PowerPoint presentations, 1 animation video explaining how the HPV test is performed, and 1 researcher-led instructional video demonstrating self-vulvar examination on a model).
Participants will also be provided with educational brochures and magnets.
For participants who do not view the presentations, weekly reminder text messages will be sent to encourage platform login and module completion.
|
|
介入なし：control group
Participants in this group will receive standard routine follow-up during the study.
After the completion of the study data collection, the web-based health education platform will also be made accessible to this group.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Personal Barriers Subscale
時間枠：Baseline and 12 weeks post-intervention
|
This subscale consists of 7 items (items 1-7) assessing personal barriers, stigma, and shame related to HPV testing.
Scores range from 7 to 49.
A higher score indicates a higher level of perceived personal barriers, meaning a less favorable attitude toward HPV testing.
|
Baseline and 12 weeks post-intervention
|
|
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Social Norms Subscale
時間枠：Baseline and 12 weeks post-intervention
|
This subscale consists of 4 items (items 8-11) assessing the influence of friends, partners, family, and social media on HPV testing.
Scores range from 4 to 28.
A higher score indicates higher negative social pressure/barriers, meaning a lower level of favorable attitudes and beliefs
|
Baseline and 12 weeks post-intervention
|
|
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Trust Subscale
時間枠：Baseline and 12 weeks post-intervention
|
This subscale consists of 6 items (items 12-17) assessing trust in the healthcare system, accuracy of HPV testing, and medical procedures.
Scores range from 6 to 42.
A higher score indicates higher levels of perceived benefit, confidence, and trust toward HPV testing.
|
Baseline and 12 weeks post-intervention
|
|
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Concerns Subscale
時間枠：Baseline and 12 weeks post-intervention
|
This subscale consists of 3 items (items 18-20) assessing concerns and worries related to the process and outcomes of HPV testing.
Scores range from 3 to 21.
A higher score indicates higher levels of concerns/negative attitudes toward HPV testing.
|
Baseline and 12 weeks post-intervention
|
協力者と研究者
スポンサー
捜査官
- スタディチェア：ZEKİYE TURAN, Phd, Associate Professor、Sakarya University Faculty of Health Sciences
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- SAU-SBE-MI-01
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
子宮頸癌の臨床試験
-
Novartis Pharmaceuticals終了しましたメラノーマ | 高度なEGFR変異体非小さな細胞肺cancer（NSCLC） | KRAS G12変異NSCLC | 食道扁平上皮がん（SCC） | ヘッド/ネックSCC | 進行した胃腸間質腫瘍（GIST） | 進行したNRAS/BRAFT WT皮膚黒色腫アメリカ, 台湾, オランダ, カナダ, スペイン, シンガポール, イタリア, 日本, 韓国
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Highlight Therapeutics積極的、募集していない平滑筋肉腫 | 悪性末梢神経鞘腫瘍 | 滑膜肉腫 | 未分化多形肉腫 | 骨の未分化高悪性度多形肉腫 | 粘液線維肉腫 | II期の体幹および四肢の軟部肉腫 AJCC v8 | III期の体幹および四肢の軟部肉腫 AJCC v8 | IIIA 期の体幹および四肢の軟部肉腫 AJCC v8 | IIIB 期の体幹および四肢の軟部肉腫 AJCC v8 | 切除可能な軟部肉腫 | 多形性横紋筋肉腫 | 切除可能な脱分化型脂肪肉腫 | 切除可能な未分化多形肉腫 | 軟部組織線維肉腫 | 紡錘細胞肉腫 | ステージ I 後腹膜肉腫 AJCC (American Joint Committee on Cancer) v8 | 体幹および四肢の I 期軟部肉腫 AJCC v8 | ステージ... およびその他の条件アメリカ
Web-Based Health Educationの臨床試験
-
University of North Texas Health Science CenterNational Institute on Minority Health and Health Disparities (NIMHD)完了
-
Istanbul Medeniyet Universityまだ募集していません
-
Saglik Bilimleri UniversitesiAnkara Oncology Research and Training Hospital積極的、募集していない
-
Abramson Cancer Center at Penn MedicineFox Chase Cancer Center完了
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; University of California, Los Angeles; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center と他の協力者積極的、募集していない